Medicus Pharma Appoints Faisal Mehmud as Chief Executive Officer of Antev
PUBLIC · MDCXAug 03, 2026
Position
Chief Executive Officer
Company
Medicus Pharma
Faisal Mehmud
West ConshohockenBiotechnologyHealthcareTherapeutics
Description
Medicus Pharma has announced the appointment of Faisal Mehmud, MD, MRCP, as the Chief Executive Officer of Antev Limited, effective August 30, 2026. This appointment strengthens the integrated leadership structure of Medicus as they advance the global development of Teverelix®.
Who to call at Medicus Pharma, and when
A new leader at Medicus Pharma brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Medicus Pharma raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Medicus Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Medicus Pharma. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Medicus Pharma
Location
100 KING STREET WEST
West Conshohocken, Pennsylvania, United States
About
Medicus Pharma Ltd. (NASDAQ:MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutic assets.
The Company is currently advancing the clinical development program of its novel Doxorubicin containing Microneedle Array (D-MNA) treatment to non-invasively treat basal cell carcinoma of the skin (BCC).
Medicus is also developing Teverelix, a next generation GnRH Antagonist as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer.
D-MNA and Teverelix, collectively represent ~$8 billion in potential market opportunity.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Medicus Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.